Watts Water Technologies, Inc. Named One of the "World's Greenest Companies 2025" by Newsweek
NORTH ANDOVER, Mass. — Watts Water Technologies, Inc. (NYSE: WTS) a leading global manufacturer of plumbing, heating, and water quality solutions, has been named one of the World's Greenest Companies by Newsweek.
Article content
Article content
To compile the list, which recognizes 750 of the most environmentally conscious and sustainable companies across 26 countries, Newsweek and its partners evaluated over 8,000 publicly listed companies. As a baseline, companies had to meet the European Union's sustainability standard, in addition to having publicly available sustainability disclosures and over 1,000 employees. Each company was scored using over 25 parameters based on greenhouse gas emissions, water usage, waste generation, and their sustainability data disclosure and commitments.
Article content
'As a leading provider of technologies and solutions designed to promote water safety, energy efficiency and water conservation around the world, this recognition demonstrates that our actions have a ripple effect,' said Robert J. Pagano, Jr., CEO, President and Chairperson of the Board. 'We are honored to once again be acknowledged by Newsweek, first as one of America's Greenest Companies for the past two years and now on a global scale. We look forward to continuing our work to combat climate change and preserve our most precious natural resource – water – for years to come.'
Article content
To learn more about Watts' Environmental, Social and Governance (ESG) efforts, read the company's 2023 Sustainability Report and visit https://www.watts.com/our-story/sustainability.
Article content
Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com.
Article content
Article content
Article content
Article content
Contacts
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
7 minutes ago
- CTV News
Chevron beats Wall Street profit estimates with record output
The logo for Chevron appears above a trading post on the floor of the New York Stock Exchange. (AP Photo/Richard Drew) HOUSTON — Chevron beat analyst estimates for second-quarter profit on Friday as record oil and gas production and lower capital expenditure helped to offset the impact of lower crude prices. The No. 2 U.S. oil major last month headed off a legal challenge from the biggest U.S. producer Exxon Mobil enabling it to close its US$55 billion acquisition of Hess. The deal includes a stake in the Stabroek Block oilfield, offshore Guyana, that Exxon operates, and should provide Chevron with a source of long-term growth to help to fund dividends into the 2030s and make Chevron's earnings more resilient to oil price volatility. International crude prices LCOc1 declined by 11 per cent during the quarter as OPEC+, the Organization of the Petroleum Exporting Countries and allied producers, increased output. Exxon Mobil also beat Wall Street estimates for second-quarter profit on Friday. 'We had strong execution, record production and exceptional cash generation,' said Chevron Chief Financial Officer Eimear Bonner in an interview. 'The financial performance was really underpinned by the stellar operational performance from across the company.' Adjusted earnings for the quarter ended June 30 were $3.1 billion, or $1.77 per share, beating consensus analyst estimates of $1.70 per share, according to data compiled by LSEG. Global production totaled 3.4 million barrels of oil equivalent per day, up from 3.3 million boed in the same period last year. Production from the Permian Basin, the biggest U.S. oilfield, reached 1 million boed during the quarter. Third-quarter production is expected to be lower by 60,000 boed due to maintenance. 'Following the clouds of uncertainty being lifted around the Hess deal, Chevron has hit the ground running with a strong set of results and beat versus market expectations,' said Biraj Borkhataria, an analyst with RBC Capital Markets, in a research note. Capital expenditure declined 7.5 per cent from the same period last year, as the company spent less on its downstream operations. Chevron raised its free cash flow guidance for 2026 to $12.5 billion. The company paid $2.9 billion in dividends and repurchased $2.6 billion worth of shares during the quarter. Although Chevron has said the Hess acquisition will allow it to increase dividends and repurchases over the long term, at least for this year, CFO Bonner said it did not expect to change its guidance of between $10 billion and $20 billion in full-year share repurchases. 'We're still in the range and we've got a strong program, and we wouldn't see a change unless we saw a sustained and significant shift in where the commodity prices are today,' she said. Earnings from oil and gas production, which make up the bulk of Chevron's profit, were $2.7 billion, down from $4.5 billion in the year-ago quarter. (Reporting by Sheila Dang in Houston and Arunima Kumar in Bengaluru; Editing by Marguerita Choy, Muralikumar Anantharaman and Barbara Lewis)
CTV News
7 minutes ago
- CTV News
Kleenex tissue maker Kimberly-Clark's sales jump on strong volumes
Boxes of Kleenex tissues are displayed in a pharmacy, Monday, April 19, 2021 in New York. (AP Photo/Mark Lennihan) Kimberly-Clark's second-quarter organic sales rose as the Kleenex tissue maker recorded its best volume growth in five years amid lower prices, sending its shares up about six per cent on Friday. The Dallas-based firm has broadened its portfolio to offer products from budget to premium price tiers, in an effort to capture demand across income levels and fend off rivals such as Procter & Gamble. 'In this challenging consumer environment, we believe it's important to meet consumers where they need us,' said CEO Mike Hsu in a statement. 'We've adjusted some entry price points, and more importantly, we're cascading features from our premium offerings into our value offerings.' The Huggies diaper maker also raised its annual profit forecast. Organic sales for the quarter ended June 30 were up 3.9 per cent, driven by a five per cent growth in overall volumes. 'Strong volume demonstrates the effectiveness of KMB's innovation ... with value positioning attracting demand across product tiers,' said CFRA analyst Ana Garcia. Prices were 1.2 per cent lower than last year. Kimberly-Clark on Friday estimated full-year incremental tariff-related costs at about US$170 million. It had warned of US$300 million in additional costs earlier in April, primarily due to U.S. President Donald Trump's levies on China. Those duties have since come down. It now expects adjusted earnings per share attributable for 2025 to grow at a low to mid-single-digit rate, compared with an earlier forecast for flat-to-positive growth on a constant-currency basis. The profit forecast still includes the International Family Care and Professional business until the close of the joint venture deal with Brazilian pulp maker Suzano in mid-year 2026, the company said. In June, Kimberly struck a US$3.4 billion deal to sell a majority stake in its international tissue business to Suzano, as part of efforts to streamline its business to control costs and drive growth in more profitable brands. --- Reporting by Savyata Mishra and Neil J Kanatt in Bengaluru; Editing by Devika Syamnath and Sriraj Kalluvila
Globe and Mail
7 minutes ago
- Globe and Mail
Zacks.com featured highlights include QuantumScape, Civeo and Agenus
For Immediate Release Chicago, IL – August 1, 2025 – Stocks in this week's article are QuantumScape Corp. QS, Civeo Corp. CVEO and Agenus Inc. AGEN. QuantumScape & 2 Other Stocks to Buy for Earnings Acceleration Top executives and analysts focus on consistent earnings growth, which reflects a company's profitability. However, earnings acceleration has an even greater impact on driving up stock prices. Studies show that successful stocks experience a speed-up in earnings before their stock prices increase. To that end, QuantumScape Corp., Civeo Corp. and Agenus Inc. are exhibiting strong earnings acceleration this month. What Is Earnings Acceleration? Earnings acceleration is the incremental growth in a company's earnings per share (EPS). In other words, if a company's quarter-over-quarter earnings growth rate increases within a stipulated time frame, it can be called earnings acceleration. In the case of earnings growth, you pay for something that is already reflected in the stock price. However, earnings acceleration helps spot stocks that haven't yet caught the attention of investors and, once secured, will invariably lead to a rally in the share price. This is because earnings acceleration considers both the direction and magnitude of growth rates. An increasing percentage of earnings growth means that the company is fundamentally sound and has been on the right track for a considerable period. Meanwhile, a sideways percentage of earnings growth indicates a period of consolidation or slowdown, while a decelerating percentage of earnings growth may drag prices down. The above criteria narrowed the universe of around 7,735 stocks to only four. Here are the top three stocks: QuantumScape QuantumScape develops solid-state lithium-metal batteries for electric vehicles in the United States. QuantumScape has a Zacks Rank #2 (Buy). QuantumScape's expected earnings growth rate for the current year is 17% (read more: QuantumScape Vs. NVIDIA: Which Stock Is a Better Buy Now?). Civeo Civeo provides hospitality services for the natural resource industry globally. Civeo has a Zacks Rank #2. CVEO's expected earnings growth rate for the current year is 69.8%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Agenus Agenus is a clinical-stage biotechnology company that develops therapies to activate immune responses against cancer globally. Agenus has a Zacks Rank #2. AGEN's expected earnings growth rate for the current year is 114.7%. You can sign up now for your 2-week free trial to the Research Wizard and start using this screen in your trading. Further, you can also create your own strategies and test them first before taking the investment plunge. The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out. Click here to sign up for a free trial to the Research Wizard today. For the rest of this Screen of the Week article please visit at: Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Strong Stocks that Should Be in the News Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>. Follow us on Twitter: Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Contact: Jim Giaquinto Company: Phone: 312-265-9268 Email: pr@ Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Agenus Inc. (AGEN): Free Stock Analysis Report Civeo Corporation (CVEO): Free Stock Analysis Report QuantumScape Corporation (QS): Free Stock Analysis Report
